Federated Hermes’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-551,091
| Closed | -$3.17M | – | 2059 |
|
2025
Q1 | $3.17M | Buy |
551,091
+714
| +0.1% | +$4.11K | 0.01% | 824 |
|
2024
Q4 | $2.75M | Buy |
550,377
+813
| +0.1% | +$4.06K | 0.01% | 859 |
|
2024
Q3 | $2.96M | Buy |
549,564
+18,343
| +3% | +$98.9K | 0.01% | 844 |
|
2024
Q2 | $1.76M | Buy |
+531,221
| New | +$1.76M | ﹤0.01% | 952 |
|
2024
Q1 | – | Sell |
-243
| Closed | -$853 | – | 2026 |
|
2023
Q4 | $853 | Sell |
243
-20,820
| -99% | -$73.1K | ﹤0.01% | 1984 |
|
2023
Q3 | $141K | Hold |
21,063
| – | – | ﹤0.01% | 1568 |
|
2023
Q2 | $177K | Buy |
+21,063
| New | +$177K | ﹤0.01% | 1565 |
|
2021
Q2 | – | Sell |
-86
| Closed | -$1K | – | 2195 |
|
2021
Q1 | $1K | Buy |
+86
| New | +$1K | ﹤0.01% | 2147 |
|
2020
Q4 | – | Sell |
-144
| Closed | -$1K | – | 2230 |
|
2020
Q3 | $1K | Buy |
+144
| New | +$1K | ﹤0.01% | 2131 |
|